(CME) CME - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12572Q1058
CME: Futures, Options, Clearing, Data
CME Group Inc. (NASDAQ:CME) is a global leader in derivatives markets, providing a comprehensive platform for trading futures and options across major asset classes. The company operates exchanges for interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals. It also offers fixed income and foreign currency trading services, catering to a diverse client base that includes professional traders, financial institutions, investors, corporations, and governments. Beyond trading, CME Group provides critical infrastructure for derivatives markets, including clearing, settling, and guaranteeing contracts, as well as trade processing and risk mitigation services. Its market data services deliver real-time and historical data, enabling market participants to make informed decisions. The company, originally founded in 1898 as the Chicago Mercantile Exchange, has evolved into one of the worlds most trusted financial market operators, with a strong reputation for innovation and operational reliability.
CME Groups business model is supported by its dominance in benchmark contracts, such as the S&P 500 futures and the Eurodollar futures, which are widely regarded as global standards for risk management. The company has also expanded into emerging areas, such as cryptocurrency derivatives, to align with evolving market demands. Its revenue streams are diversified across transaction fees, clearing services, and market data, providing resilience against market volatility. CME Groups strategic focus on advancing sustainability initiatives and fostering digital transformation further underscores its commitment to long-term growth and industry leadership.
Additional Sources for CME Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CME Stock Overview
Market Cap in USD | 101,063m |
Sector | Financial Services |
Industry | Financial Data & Stock Exchanges |
GiC Sub-Industry | Financial Exchanges & Data |
IPO / Inception | 2002-12-06 |
CME Stock Ratings
Growth Rating | 69.9 |
Fundamental | 74.7 |
Dividend Rating | 76.3 |
Rel. Strength | 13.8 |
Analysts | 3.39/5 |
Fair Price Momentum | 312.49 USD |
Fair Price DCF | 227.77 USD |
CME Dividends
Dividend Yield 12m | 4.19% |
Yield on Cost 5y | 6.99% |
Annual Growth 5y | 12.00% |
Payout Consistency | 95.5% |
CME Growth Ratios
Growth Correlation 3m | 82.6% |
Growth Correlation 12m | 95.9% |
Growth Correlation 5y | 74.6% |
CAGR 5y | 13.41% |
CAGR/Max DD 5y | 0.42 |
Sharpe Ratio 12m | 2.04 |
Alpha | 34.32 |
Beta | 0.117 |
Volatility | 19.68% |
Current Volume | 1620.1k |
Average Volume 20d | 2085.2k |
As of May 09, 2025, the stock is trading at USD 281.99 with a total of 1,620,116 shares traded.
Over the past week, the price has changed by +1.76%, over one month by +10.57%, over three months by +17.19% and over the past year by +39.28%.
Yes, based on ValueRay Fundamental Analyses, CME (NASDAQ:CME) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 74.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CME as of May 2025 is 312.49. This means that CME is currently undervalued and has a potential upside of +10.82% (Margin of Safety).
CME has received a consensus analysts rating of 3.39. Therefor, it is recommend to hold CME.
- Strong Buy: 4
- Buy: 3
- Hold: 7
- Sell: 4
- Strong Sell: 0
According to ValueRays Forecast Model, CME CME will be worth about 337.5 in May 2026. The stock is currently trading at 281.99. This means that the stock has a potential upside of +19.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 270.4 | -4.1% |
Analysts Target Price | 270.4 | -4.1% |
ValueRay Target Price | 337.5 | 19.7% |